Sfoglia per Autore
Ibrutinib: from bench side to clinical implications
2015 Grisafi D.; Maestro A.; Grumi C.; Piazzoni L.; Tirone G.; Fiore W.; Tessari R.; Gianardi V.; Gatti M.; Tasca F.; Generali D.; Ravelli A.; Lanza F.; Scaglione F.
Septic shock due to NSTI caused by Actinomyces Turicensis: the role of clinical pharmacology. Case report and review of the literature
2017 Gatti M.; Gasparini L.E.; Grimaldi C.M.; Abbati D.; Clemente S.; Brioschi P.R.; Fumagalli R.; Scaglione F.
FreeStyle Libre flash glucose monitoring system in pregnant woman with type 1 diabetes: a focus on accuracy
2019 Gatti M.; Amato A.M.L.; Bruttomesso D.
Feasibility of FreeStyle Libre Flash Glucose Monitoring System in pregnant woman affected by type 1 diabetes
2019 Gatti M.
Intensive multidisciplinary management in critical care patients affected by severe necrotizing soft tissue infections: a cooperative method to improve the efficacy of treatment
2019 Gatti M.; Gasparini L.E.; Laratta M.; Sigurta A.; Rossi A.; Brioschi P.; Chiara O.; Vismara C.; Scaglione F.; Arlati S.
Comparative Effectiveness and Safety of Direct Oral Anticoagulants: Overview of Systematic Reviews
2019 Raschi E.; Bianchin M.; Gatti M.; Squizzato A.; De Ponti F.
Relationship between adverse drug reactions to antibacterial agents and the Klebsiella pneumoniae carbapenemase-producing (KPC) Klebsiella pneumoniae outbreak: Insight from a pharmacovigilance study
2019 Gatti M.; Raschi E.; De Ponti F.
The Complex Management of Atrial Fibrillation and Cancer in the COVID-19 Era: Drug Interactions, Thromboembolic Risk, and Proarrhythmia
2020 Gatti M.; Raschi E.; Poluzzi E.; Martignani C.; Salvagni S.; Ardizzoni A.; Diemberger I.
Liver Injury with Ulipristal Acetate: Exploring the Underlying Pharmacological Basis
2020 Gatti M.; Poluzzi E.; De Ponti F.; Raschi E.
Lessons to be Learnt from Real-World Studies on Immune-Related Adverse Events with Checkpoint Inhibitors: A Clinical Perspective from Pharmacovigilance
2020 Raschi E.; Gatti M.; Gelsomino F.; Ardizzoni A.; Poluzzi E.; De Ponti F.
Adaptive trials of new antimicrobials for infections with carbapenem-resistant, Gram-negative bacteria
2020 Gatti M.; Giannella M.; Scudeller L.; Viale P.
Quantification of 1,3-β-d-glucan by Wako β-glucan assay for rapid exclusion of invasive fungal infections in critical patients: A diagnostic test accuracy study
2020 Cento V.; Alteri C.; Mancini V.; Gatti M.; Lepera V.; Mazza E.; Moioli M.C.; Merli M.; Colombo J.; Orcese C.A.; Bielli A.; Torri S.; Gasparini L.E.; Vismara C.; De Gasperi A.; Brioschi P.; Puoti M.; Cairoli R.; Lombardi G.; Perno C.F.
Reply-Letter to the editor - The valuable support of spontaneous reporting systems in exploring safety profile of dietary supplements
2020 Gatti M.; Ippoliti I.; Poluzzi E.; Antonazzo I.C.; Moro P.A.; Moretti U.; Menniti-Ippolito F.; Mazzanti G.; De Ponti F.; Raschi E.
Pharmacokinetic analysis investigating gentamicin dosing in a major burned patient complicated by septic shock
2020 Gatti M.
Advances in the therapy of bacterial bloodstream infections
2020 Giannella M.; Bartoletti M.; Gatti M.; Viale P.
Assessing the association between fluoroquinolones and emerging adverse drug reactions raised by regulatory agencies: An umbrella review
2020 Gatti M.; Bianchin M.; Raschi E.; De Ponti F.
Risk of bradyarrhythmia related to ticagrelor: A systematic review and meta-analysis
2020 Pujade I.; Perino J.; Mathieu C.; Arnaud M.; Raschi E.; Gatti M.; Bezin J.; Salvo F.
In vivo acquisition and risk of inter-species spread of blaKPC-3-plasmid from Klebsiella pneumoniae to Serratia marcescens in the lower respiratory tract
2020 Bielli A.; Piazza A.; Cento V.; Comandatore F.; Lepera V.; Gatti M.; Brioschi P.; Vismara C.; Bandi C.; Perno C.F.
Assessment of a pk/pd target of continuous infusion beta-lactams useful for preventing microbiological failure and/or resistance development in critically ill patients affected by documented gram-negative infections
2021 Gatti M.; Cojutti P.G.; Pascale R.; Tonetti T.; Laici C.; Dell'olio A.; Siniscalchi A.; Giannella M.; Viale P.; Pea F.
Drug repurposing in the covid-19 era: Insights from case studies showing pharmaceutical peculiarities
2021 Gatti M.; De Ponti F.
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile